St Bonnet-de-Mure, France

Frédéric Reynard


Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • St Bonnet-de-Mure, FR (2018 - 2019)
  • Saint-Bonnet-de-Mure, FR (2019)

Company Filing History:


Years Active: 2018-2019

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Frédéric Reynard: Innovator in Veterinary Vaccines

Introduction

Frédéric Reynard is a notable inventor based in St Bonnet-de-Mure, France. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for animal health. With a total of four patents to his name, Reynard's work focuses on innovative solutions to combat viral infections in livestock.

Latest Patents

Reynard's latest patents include groundbreaking inventions such as FCV recombinant vaccines and their uses. This invention encompasses vaccines or compositions containing FCV antigens, which are crucial for protecting animals against FCV infection. Additionally, he has developed FMDV and E2 fusion proteins and their uses. This patent includes vaccines or compositions containing FMDV antigens, aimed at safeguarding various livestock species, including ovines, bovines, caprines, and swines, from FMDV infections.

Career Highlights

Throughout his career, Frédéric Reynard has worked with prominent companies in the veterinary field. Notably, he has been associated with Boehringer Ingelheim Animal Health USA Inc. and Merial Limited. His experience in these organizations has contributed to his expertise in vaccine development and animal health solutions.

Collaborations

Reynard has collaborated with several professionals in his field, including Jean-Christophe Francis Audonnet and Natalia Ines Bomchil. These collaborations have likely enhanced his research and development efforts, leading to innovative vaccine solutions.

Conclusion

Frédéric Reynard's contributions to veterinary medicine through his patents and collaborations highlight his commitment to improving animal health. His innovative work in vaccine development continues to have a significant impact on the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…